These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11399702)

  • 1. Angiotensin-converting enzyme inhibitor therapy improves respiratory muscle strength in patients with heart failure.
    Coirault C; Hagège A; Chemla D; Fratacci MD; Guérot C; Lecarpentier Y
    Chest; 2001 Jun; 119(6):1755-60. PubMed ID: 11399702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-dose hypotension after angiotensin-converting enzyme (ACE) inhibitors in chronic heart failure: a comparison of enalapril and perindopril. Slovak Investigator Group.
    Vítovec J; Spinar J
    Eur J Heart Fail; 2000 Sep; 2(3):299-304. PubMed ID: 10938492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of the first dose hypotensive effects of captopril and perindopril in patients with heart failure.
    Cardiovasc Drugs Ther; 2001 Nov; 15(6):501-6. PubMed ID: 11916359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
    Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R
    J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACE inhibitors in heart failure--switching from enalapril to perindopril.
    Masuell M; Brusca G; Pardo A; Piñeiro D; Checkerdhemian S; Forcada P
    Curr Med Res Opin; 2002; 18(5):296-302. PubMed ID: 12240792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inspiratory muscle strength is a determinant of maximum oxygen consumption in chronic heart failure.
    Chua TP; Anker SD; Harrington D; Coats AJ
    Br Heart J; 1995 Oct; 74(4):381-5. PubMed ID: 7488451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
    Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L
    Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative haemodynamic responses to the first dose of short- and long-acting ACE inhibitors in patients with congestive heart failure.
    Anthopoulos L; Apostolou T; Bonoris P; Foussas S; Lefkos N; Zombolos S
    Curr Med Res Opin; 2001; 17(4):290-7. PubMed ID: 11922403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addition of valsartan to an angiotensin-converting enzyme inhibitor improves cardiac sympathetic nerve activity and left ventricular function in patients with congestive heart failure.
    Kasama S; Toyama T; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    J Nucl Med; 2003 Jun; 44(6):884-90. PubMed ID: 12791814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of perindopril on long-term clinical outcome of patients with coronary artery disease and preserved left ventricular function.
    Bertrand ME; Remme WJ; Fox KM; Ferrari R; Simoons ML;
    Int J Cardiol; 2007 Sep; 121(1):57-61. PubMed ID: 17270296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of angiotensin converting enzyme inhibitor with different doses on plasma brain natriuretic peptide and norepinephrine in patients with chronic heart failure].
    Song HM; Zhang J; Deng B; Luo M
    Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(25):1737-40. PubMed ID: 16253158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effect of perindopril on cardiac sympathetic nerve activity and brain natriuretic peptide in patients with chronic heart failure: comparison with enalapril.
    Tsutamoto T; Tanaka T; Sakai H; Nishiyama K; Fujii M; Yamamoto T; Nakae I; Ohnishi M; Wada A; Horie M
    Circ J; 2008 May; 72(5):740-6. PubMed ID: 18441453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of perstarium on the systolic and diastolic functions of the myocardium in patients with chronic cardiac failure].
    Fomina IG; Georgadze ZO; Sinitsyna MG; Gaĭdamakina NE; Nagieva AZ; Matveev VV
    Klin Med (Mosk); 2001; 79(8):20-3. PubMed ID: 11588778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study.
    MacFadyen RJ; Lees KR; Reid JL
    Br Heart J; 1991 Sep; 66(3):206-11. PubMed ID: 1657084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of pharmacotherapy with perindopril, lozartan potassium and its combination in elderly patients with chronic heart failure].
    Svetyy LI; Lopukhova VA; Tarasenko IV
    Adv Gerontol; 2015; 28(3):500-503. PubMed ID: 28509487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perindopril: in congestive heart failure.
    Simpson D; Noble S; Goa KL
    Drugs; 2002; 62(9):1367-77; discussion 1378-9. PubMed ID: 12076191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of perindopril on cardiac sympathetic nerve activity in patients with congestive heart failure: comparison with enalapril.
    Kasama S; Toyama T; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):964-71. PubMed ID: 15803314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and long-term efficacy of perindopril in severe chronic congestive heart failure.
    Flammang D; Waynberger M; Chassing A
    Am J Cardiol; 1993 Jun; 71(17):48E-56E. PubMed ID: 8328368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Change of circadian pattern of arterial pressure in patients with congestive heart failure treated with perindopril, an inhibitor of angiotensin-converting enzyme (ACE)].
    Tereshchenko SN; Kobalova ZhD; Demidova IV; Moiseev VS
    Ter Arkh; 1997; 69(12):40-3. PubMed ID: 9503533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perindopril for elderly people with chronic heart failure: the PEP-CHF study. The PEP investigators.
    Cleland JG; Tendera M; Adamus J; Freemantle N; Gray CS; Lye M; O'Mahony D; Polonski L; Taylor J
    Eur J Heart Fail; 1999 Aug; 1(3):211-7. PubMed ID: 10935667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.